Cargando…
RHOJ controls EMT-associated resistance to chemotherapy
The resistance of cancer cells to therapy is responsible for the death of most patients with cancer(1). Epithelial-to-mesenchymal transition (EMT) has been associated with resistance to therapy in different cancer cells(2,3). However, the mechanisms by which EMT mediates resistance to therapy remain...
Autores principales: | Debaugnies, Maud, Rodríguez-Acebes, Sara, Blondeau, Jeremy, Parent, Marie-Astrid, Zocco, Manuel, Song, Yura, de Maertelaer, Viviane, Moers, Virginie, Latil, Mathilde, Dubois, Christine, Coulonval, Katia, Impens, Francis, Van Haver, Delphi, Dufour, Sara, Uemura, Akiyoshi, Sotiropoulou, Panagiota A., Méndez, Juan, Blanpain, Cédric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076223/ https://www.ncbi.nlm.nih.gov/pubmed/36949199 http://dx.doi.org/10.1038/s41586-023-05838-7 |
Ejemplares similares
-
The Role of RhoJ in Endothelial Cell Biology and Tumor Pathology
por: Shi, Ting-Ting, et al.
Publicado: (2016) -
Arhgef15 Promotes Retinal Angiogenesis by Mediating VEGF-Induced Cdc42 Activation and Potentiating RhoJ Inactivation in Endothelial Cells
por: Kusuhara, Sentaro, et al.
Publicado: (2012) -
Rho GTPase RhoJ is Associated with Gastric Cancer Progression and Metastasis
por: Kim, Chan, et al.
Publicado: (2016) -
RhoJ interacts with the GIT–PIX complex and regulates focal adhesion disassembly
por: Wilson, Eleanor, et al.
Publicado: (2014) -
The RhoJ-BAD signaling network: An Achilles’ heel for BRAF mutant melanomas
por: Ruiz, Rolando, et al.
Publicado: (2017)